Sg Americas Securities, LLC Rocket Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

$24.4 Billion
Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 54,921 shares of RCKT stock, worth $589,851. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,921

Previous 6,128 796.23%

Holding current value

$589,851

Previous $113,000 510.62%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$11.35 - $18.82 $553,800 - $918,284	48,793 Added 796.23%	54,921 $690,000
Q3 2024 Oct 03, 2024	BUY	$17.6 - $25.88 $107,852 - $158,592	6,128 New	6,128 $113,000
Q1 2024 May 06, 2024	SELL	$26.16 - $30.74 $251,319 - $295,319	-9,607 Reduced 52.29%	8,765 $236,000
Q4 2023 Jan 12, 2024	SELL	$16.78 - $31.94 $1.07 Million - $2.03 Million	-63,575 Reduced 77.58%	18,372 $551,000
Q3 2023 Oct 13, 2023	BUY	$15.07 - $24.05 $1.23 Million - $1.97 Million	81,947 New	81,947 $1.68 Million
Q1 2023 Apr 28, 2023	BUY	$15.79 - $22.6 $21,158 - $30,284	1,340 Added 13.05%	11,612 $199,000
Q4 2022 Feb 02, 2023	SELL	$15.5 - $22.76 $342,457 - $502,859	-22,094 Reduced 68.26%	10,272 $201,000
Q3 2022 Oct 31, 2022	SELL	$12.37 - $18.41 $208,756 - $310,687	-16,876 Reduced 34.27%	32,366 $517,000
Q2 2022 Jul 29, 2022	BUY	$7.96 - $16.64 $391,966 - $819,386	49,242 New	49,242 $678,000
Q1 2022 Apr 29, 2022	SELL	$13.16 - $23.68 $1.05 Million - $1.89 Million	-79,622 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$21.52 - $36.02 $1.26 Million - $2.12 Million	58,775 Added 281.94%	79,622 $1.74 Million
Q3 2021 Nov 01, 2021	BUY	$27.42 - $48.97 $468,635 - $836,946	17,091 Added 455.03%	20,847 $623,000
Q2 2021 Aug 12, 2021	SELL	$39.41 - $47.25 $227,671 - $272,963	-5,777 Reduced 60.6%	3,756 $166,000
Q1 2021 May 13, 2021	BUY	$43.34 - $65.91 $117,841 - $179,209	2,719 Added 39.9%	9,533 $423,000
Q4 2020 Feb 04, 2021	SELL	$23.3 - $59.57 $43,967 - $112,408	-1,887 Reduced 21.69%	6,814 $374,000
Q3 2020 Nov 09, 2020	BUY	$20.5 - $28.59 $2,685 - $3,745	131 Added 1.53%	8,701 $199,000
Q2 2020 Jul 20, 2020	BUY	$13.32 - $22.61 $114,152 - $193,767	8,570 New	8,570 $179,000

Others Institutions Holding RCKT

# of Institutions

210

Shares Held

93.1M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $813M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Rocket Pharmaceuticals, Inc. Transaction History